How frequent is nocturia in medical students?

Year 2017, Volume: 3 Issue: 1, 68 - 72, 04.03.2017

Burhan Coskun , Turgut Yurdakul Onur Kaygisiz , Nizameddin Koca , İsmet Yavascaoglu

https://doi.org/10.18621/eurj.267257

Abstract

Objective. Nocturia is the most common lower urinary tract symptom and its prevalence
increases with age. The frequency of nocturia and related bother are not widely
investigated in young adults in the literature. In this study we aimed to
investigate frequency, bothersome and relation of nocturia with anxiety in
medical students. Methods. A
questionnaire consisting of 19 items were sent to medical students via social
media by using Survey Monkey^TM software. Questions include demographic characteristics, fluid intake habits, voiding symptoms, and bother
score related to nocturia. Also, Beck Anxiety Inventory was used to measure
level of anxiety. Results. A total of
221 students replied the survey. The mean age was 20.7±2.10. Forty-seven (21.3%) students had nocturia. The rate of nocturia was 27.4%
and 13.4% in women and men, respectively (p=0.011). The frequency of  nocturia per night  was 80.2%, 17.3% and 2.2% (1, 2, 3 times; respectively). While the frequency of nocturia was found to be related with
bother scores there were no relation of gender with degree of bother. Conclusion. Nocturia is
frequent in medical students, especially in women. Commonly, nocturia do not
cause bother in young adults with one episode and  it is not related with anxiety.

Keywords

Nocturia, young adults, bother

References

• [1] van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179-83.
• [2] Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 2006;50:1306-14; discussion 1314-5.
• [3] FitzGerald MP, Litman HJ, Link CL, McKinlay JB. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: Results from the BACH survey. J Urol 2007;177:1385-9.
• [4] Kupelian V, Fitzgerald MP, Kaplan SA, Norgaard JP, Chiu GR, Rosen RC. Association of nocturia and mortality: results from the Third National Health and Nutrition Examination Survey. J Urol 2011;185:571-7.
• [5] Weiss JP, Blaivas JG, Bliwise DL, Dmochowski RR, Dubeau CE, Lowe FC, et al. The evaluation and treatment of nocturia: a consensus statement. BJU Int 2011;108:6-21.
• [6] Golabek T, Skalski M, Przydacz M, Swierkosz A, Siwek M, Golabek K, et al. Lower urinary tract symptoms, nocturia and overactive bladder in patients with depression and anxiety. Psychiatr Pol 2016;50:417-30.
• [7] Leyfer OT, Ruberg JL, Woodruff-Borden J. Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord 2006;20:444-58.
• [8] Tunay S, Soygut G. [The reliability and validity of Turkish brief measure of worry severity based on Turkish university students]. Turk Psikiyatri Derg 2009;20:68-74. [Article in Turkish]
• [9] MacDiarmid S, Al-Shukri S, Barkin J, Fianu-Jonasson A, Grise P, Herschorn S, et al.; BESIDE Investigators. Mirabegron as add-on treatment to solifenacin in patients with incontinent overactive bladder and an inadequate response to solifenacin monotherapy. J Urol 2016;196:809-18.
• [10] Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, et al. EAU Guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 2015;67:1099-109.
• [11] Bosch JLHR, Weiss JP. The prevalence and causes of nocturia. J Urol 2010;184:440-6.
• [12] Tikkinen KA, Johnson TM, 2nd, Tammela TL, Sintonen H, Haukka J, Huhtala H, et al. Nocturia frequency, bother, and quality of life: how often is too often? A population-based study in Finland. Eur Urol 2010;57:488-96.
• [13] Hernandez C, Estivill E, Prieto M, Badia X. Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Curr Med Res Opin 2008;24:1033-38.
• [14] Yoshimura K, Terada N, Matsui Y, Terai A, Kinukawa N, Arai Y. Prevalence of and risk factors for nocturia: analysis of a health screening program. Int J Urol 2004;11:282-7.
• [15] Asplund R, Henriksson S, Johansson S, Isacsson G. Nocturia and depression. BJU Int 2004;93:1253-6.